Vir Biotechnology, Inc. — Investor Relations & Filings
Vir Biotechnology, Inc. is a clinical-stage immunology company that leverages the immune system to treat and prevent serious infectious diseases and other conditions. The company's pipeline is built on two primary technology platforms: a next-generation antibody platform for identifying and optimizing therapeutic candidates, and the PRO-XTEN® protease-releasable masking technology for applications in oncology. Vir's main therapeutic area is infectious diseases, featuring a leading program for chronic hepatitis delta, and is complemented by strategic programs in oncology. The company has demonstrated its capabilities by developing antibody-based medicines for significant health challenges, including COVID-19 and Ebola.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 4 SUBMISSION | 2022-07-21 | English | |
| 8-K | 2022-07-14 | English | |
| FORM 4 SUBMISSION | 2022-07-13 | English | |
| FORM 4 SUBMISSION | 2022-07-12 | English | |
| FORM 4 SUBMISSION | 2022-06-22 | English | |
| FORM 4 SUBMISSION | 2022-06-13 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 13035631 | FORM 4 SUBMISSION | 2022-07-21 | English | ||
| 13035630 | 8-K | 2022-07-14 | English | ||
| 13035633 | FORM 4 SUBMISSION | 2022-07-13 | English | ||
| 13035634 | FORM 4 SUBMISSION | 2022-07-12 | English | ||
| 13035635 | FORM 4 SUBMISSION | 2022-06-22 | English | ||
| 13035636 | FORM 4 SUBMISSION | 2022-06-13 | English | ||
| 13035637 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-11 | English | ||
| 13035638 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-11 | English | ||
| 13035639 | FORM 4 SUBMISSION | 2022-06-09 | English | ||
| 13035640 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-07 | English | ||
| 13035641 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-07 | English | ||
| 13035642 | 8-K | 2022-06-03 | English | ||
| 13035643 | FORM 4 SUBMISSION | 2022-05-26 | English | ||
| 13035644 | FORM 4 SUBMISSION | 2022-05-26 | English | ||
| 13035645 | FORM 4 SUBMISSION | 2022-05-26 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Vir Biotechnology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32538/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32538 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32538 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32538 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32538}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vir Biotechnology, Inc. (id: 32538)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.